RECOVERY results do not support aspirin use in this setting Treatment with aspirin did not bring about any clinically meaningful improvements in outcomes among patients hospitalized with Covid-19 in the large, randomized, open-label RECOVERY trial. Aspirin was not associated with reductions in 28-day mortality or in the risk of progression to invasive mechanical ventilation in